CP Foods reports Q1 2025 profit surge, exceeding target by sixfold
The surge reflects CP Foods’ strong adaptability to economic and geopolitical challenges.
Available in other languages:
Content available at:
ไทย (Thai)
Thailand’s Charoen Pokphand Foods (CP Foods) reported a record-breaking Q1 2025, with net profit soaring 642% to year-on-year.
The surge reflects CP Foods’ resilience amid economic and geopolitical challenges, supported by strict disease prevention systems and high occupational health and safety standards implemented across its operations.
Drivers of performance
CEO Prasit Boondoungprasert attributed the impressive Q1 results to efficiency improvements and cost reductions throughout the entire supply chain.
Furthermore, outbreaks of avian influenza in several countries, along with the ongoing impact of African swine fever (ASF), have led to a decrease in global poultry and swine supplies.
Meanwhile, raw material costs have remained at favorable levels. These factors have enabled CP Foods to surpass its performance targets both domestically and in over 10 countries where it operates.
Production stability and product quality
CP Foods’ strong Q1 performance reflects the dedication of its global workforce and its long-term resilience across diverse environments.
Ongoing investments in innovation, technology, and the implementation of IT management systems—alongside its commitment to biosecurity and systematic disease prevention in livestock farming—reinforce the company’s strength throughout the supply chain.
These factors ensure stable production and consistently high product quality.
Optimistic outlook
Mr Prasit emphasized that CP Foods’ overall performance for 2025 is expected to surpass the previous year’s results. This optimism is driven by the company’s ongoing strategic initiatives and industry recovery from past challenges.
Regarding concerns surrounding US tariff policies, CP Foods remains unaffected, as it prioritizes locally produced, affordable food in more than 10 countries. Exports account for only 4-5% of total sales, primarily serving Asian and European markets, with the US market accounting for just 0.3%.
Robust disease prevention
Amid global animal disease outbreaks and the reemergence of Covid-19, CP Foods has reinforced its comprehensive risk management, targeted investments in promising sectors, and, most critically, elevated safety standards throughout its operations.
This includes robust disease prevention across the supply chain and stringent occupational health and safety measures to safeguard business continuity.
